Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells.
Sign Up to like & getrecommendations! Published in 2025 at "Molecular oncology"
DOI: 10.1002/1878-0261.70155
Abstract: Rearranged during transfection (RET) fusions drive subsets of non-small cell lung cancer (NSCLC) and papillary thyroid carcinoma (PTC). Despite new selective RET tyrosine kinase inhibitors (TKIs), resistance usually occurs and is often driven by RET-independent… read more here.
Keywords: ret src; cancer; ret; ret fusion ... See more keywords